6533b7d0fe1ef96bd125a36f
RESEARCH PRODUCT
A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis.
Javier CañuetoOnofre SanmartínS. PuigPedro RedondoAntonio Tejera-vaquerizoRafael Botella-estradasubject
Oncologymedicine.medical_specialtyPoor prognosisHistologyCutaneous squamous cell carcinomaSkin Neoplasmsbusiness.industryIncidence (epidemiology)Locally advancedCancerDermatologymedicine.diseasePathology and Forensic Medicine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisInternal medicineCarcinoma Squamous CellMedicineHumansmedicine.symptombusinessConfusionNeoplasm Stagingdescription
Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer in humans and its incidence is both underestimated and on the rise. cSCC is referred to in the literature as high-risk cSCC, locally advanced cSCC, metastatic cSCC, advanced cSCC, and aggressive cSCC. These terms can give rise to confusion and are not always well defined. In this review, we aim to clarify the concepts underlying these terms with a view to standardizing the description of this tumor, something we believe is necessary in light of the new drugs that have been approved or are in development for cSCC.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2020-05-01 | Actas dermo-sifiliograficas |